Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer
Objective: c-Met is expressed in human ovarian cancer tissues, and its phosphorylation activates signaling cascades that might affect the behavior of cancer cells. In this study, we evaluated the association of c-Met and phosphorylated c-Met (phospho-c-Met) expressions with the clinical outcomes of...
Main Authors: | Ling Lim, Chao-Chih Wu, Yun-Ting Hsu, Fang-Ju Sun, Chih-Long Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455918302948 |
Similar Items
-
Antitumor effects of BMS-777607 on ovarian cancer cells with constitutively activated c-MET
by: Chao-Chih Wu, et al.
Published: (2019-01-01) -
Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
by: Huimin Wang, et al.
Published: (2015-02-01) -
Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer
by: Sun W, et al.
Published: (2013-09-01) -
Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
by: Huang L, et al.
Published: (2020-08-01) -
Structure–activity relationship of antioxidant dipeptides: Dominant role of Tyr, Trp, Cys and Met residues
by: Lin Zheng, et al.
Published: (2016-03-01)